Centrient Pharmaceuticals
Job de Heer currently serves as the Lead Document Controller in the Maintenance & Engineering department at Centrient Pharmaceuticals, managing the standardization and archiving of technical documents. Previously, Job was a Business Consultant for Joy Of Business, assisting various companies with growth strategies, and held the position of Project Manager at Heijmans, where management of civil engineering projects was key. Job further demonstrated expertise in business development as a Business Development Manager at Applied Drone Innovations B.V., and gained foundational experience in commercial operations and sales through roles at DSM and Toll Global Forwarding. Job holds bachelor's degrees in Business Administration with a focus on International Business and Asian Business from Rotterdam University of Applied Sciences and Sophia University.
This person is not in any teams
This person is not in any offices
Centrient Pharmaceuticals
2 followers
Centrient Pharmaceuticals is the global business-to-business leader in sustainable, enzymatic antibiotics, next generation statins and anti-fungals. We produce and sell intermediates and active pharmaceutical ingredients (APIs), as well as our own tablets, capsules and other finished dosage forms (FDFs). We stand proudly at the centre of modern healthcare, as a maker of essential and life-saving medicines. With our commitment to Quality, Reliability and Sustainability at the heart of everything we do, our over 1,800 employees work continuously to meet our customers’ needs. We work towards a sustainable future by actively participating in the fight against antimicrobial resistance. Founded 150 years ago as the ‘Nederlandsche Gist- en Spiritusfabriek’, our company was known as Gist Brocades and more recently DSM Sinochem Pharmaceuticals. Headquartered in Rotterdam (Netherlands), we have production facilities and sales offices in China, India, the Netherlands, Spain, the United States and Mexico. Centrient Pharmaceuticals is owned by Bain Capital Private Equity, a leading global private investment firm.